Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.
about
Imaging fungal infections in childrenβ-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)The epidemiology and diagnosis of invasive candidiasis among premature infantsLevels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida speciesHigh Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.β-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Evaluation of a Novel Plasma (1,3)-β-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric PatientsRole of nutrients in the development of neonatal immune response.The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in ChildrenCerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.Managing fungal and viral infections in pediatric leukemia.Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.Invasive aspergillosis in children with acquired immunodeficiencies.Application of diagnostic markers to invasive aspergillosis in children.Invasive fungal infections in newborns and current management strategies.Invasive candidiasis and candidaemia in neonates and children: update on current guidelines.Improved detection of deeply invasive candidiasis with DNA aptamers specific binding to (1→3)-β-D-glucans from Candida albicans.Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?The Diagnostic Value of (1 → 3)-Beta-D-glucans and Galactomannan Assays in Children Suffering from Bacteremia in Pediatric Intensive Care Unit.Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.Progress in the Diagnosis of Invasive Fungal Disease in Children.Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.Current Algorithms in Fungal Diagnosis in the Immunocompromised Host.Diagnosis of invasive fungal diseases in pediatric patients.Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysisElevated serum beta-D-glucan levels in immunocompromised children with clinical suspicion for Pneumocystis jirovecii pneumonia(1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate.Pediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children.Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis.Pediatric Invasive Aspergillosis.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Diagnostic Approaches for Invasive Aspergillosis-Specific Considerations in the Pediatric Population.Persistence of high-level (1,3)-β-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient.Invasive Aspergillosis in Children: Update on Current Guidelines
P2860
Q26766376-F476B0D4-0E42-473F-91AD-DBA16B91440AQ26825753-F3F27AB7-B78C-494D-88E4-592FFB63583CQ26861652-081E6D77-6F00-4777-BC16-CC4A37ECD218Q33711043-A9CA3BDC-9857-403A-A095-F40B0DFEE787Q33825648-B70EB1F3-6E14-4E72-8719-A40A938F34AAQ34505582-0A4B6862-A678-4701-B965-7FC5F121D3D8Q35297182-9E51679C-EB23-4F1C-B430-B5F244CD3438Q35868758-DD0C045C-A9F6-4CFD-8D0B-8557596F8EBCQ35968648-3104A378-8B76-486C-BADB-0000F53F2A58Q36051649-941E9D9A-226D-4981-9CA2-3783C22EEB73Q36630700-9C4E7896-0248-45EA-9D97-7D27BACF9E2DQ36949545-E85F85A6-41D0-4068-A485-E1A5BB6928DBQ37810281-C30FC4D9-2BC8-4168-93B0-3B05E671CBDDQ37854718-4FA64F6D-184C-46C2-AF3F-9AABAD1F0D66Q37954958-84261316-4A2C-41FA-BE8C-6F996A8B31B6Q38066612-750D7233-85EC-4B3E-ABEE-FBA2A42FAA9EQ38119554-363165CA-2550-4A0D-8C81-EAB9C2885A9CQ38263282-ED569151-1898-4A7C-A6CF-C0E14E3A4DB2Q38294178-01225A62-6B7D-4635-BF0A-20F4F13FD4F4Q38611989-AAFA63F6-AC91-42A8-9B65-2B069FCB70A4Q38693242-5F120A3E-C3E3-450F-AC8E-B482668EC526Q39121179-B56E4290-EACD-4868-AC11-C9778C1A6A58Q39175053-33C25EA8-7C60-45B3-8FF3-4B8CDC79BBBBQ39355509-255BD131-5F24-4252-A299-03F3F2760FC1Q39416559-13264B5C-C11B-439C-B64D-CDCDD63A1CDCQ40266645-665178AF-123F-4BC9-B2E5-3304CA6D3CEEQ40454880-8E816B8A-6C51-49B8-9239-E18FD34D8F71Q40524695-71EE6CF3-311A-44CE-852B-B10E31D5FFC4Q41996456-E5A3AB02-421A-4011-A3B4-3373F358134AQ42559150-EDD11172-B875-4BF1-867C-B9568D7EFF70Q42849189-91FBCACB-7435-4DD4-B217-5F52D128590EQ46253117-9C36DAF4-9B48-40EA-AE2E-3225EDE4623EQ49182676-0F91A9B4-74D9-4AF8-8E67-693F04286AB9Q49612984-0E64C73C-1EBB-409C-ACBF-0BFE2C178CE0Q49612998-35DECD25-89D8-43A8-8832-9E412B1598C8Q50072321-4B94A013-EEFE-4453-AB72-6A506C305DDFQ52720488-5026D76B-D9FA-49EE-A70C-4C560AA0779AQ55460711-58A59F4C-8169-4663-A3D8-FD4793AA80AFQ58775551-EC35634A-7BB1-4BF7-BED2-9323B11D353F
P2860
Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.
@ast
Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.
@en
type
label
Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.
@ast
Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.
@en
prefLabel
Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.
@ast
Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.
@en
P2093
P2860
P356
P1476
Quantification of 1,3-beta-D-g ...... assay in a pediatric setting.
@en
P2093
Barbara D Alexander
Daniel K Benjamin
Malcolm A Finkelman
P Brian Smith
William J Steinbach
P2860
P304
P356
10.1128/CVI.00025-07
P577
2007-05-30T00:00:00Z